drugset / Trial / NCT01651572

Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia

NCT01651572

Phase 4 Completed 120 enrolled Azienda Ospedaliera di Padova
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to determine the incidence of post-operative residual curarization in our patients and to determine if Cisatracurium and Rocuronium behave differently from each other in terms of residual curarization.

Timeline

Start
2012-07
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisatracurium Small molecule 0.1 mg/kg
Subject Rocuronium Other / unclassified 0.15 mg/kg